SGLT-2 Inhibitors versus GLP-1 Receptor Agonists for Dementia and Depression in Type 2 Diabetes Mellitus: A Meta-Analysis.

Pan R, Wang B, Li Y, Li H, Liang X, Zhang Y, Liu X, Huang X, Wang R, Ji H, Zhao Y

Open source

DOI
10.2147/dmso.s628886
Published
2026
Container
Diabetes, metabolic syndrome and obesity : targets and therapy
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.2147/dmso.s628886,
  title = {SGLT-2 Inhibitors versus GLP-1 Receptor Agonists for Dementia and Depression in Type 2 Diabetes Mellitus: A Meta-Analysis.},
  author = {Pan R and Wang B and Li Y and Li H and Liang X and Zhang Y and Liu X and Huang X and Wang R and Ji H and Zhao Y},
  year = {2026},
  journal = {Diabetes, metabolic syndrome and obesity : targets and therapy},
  doi = {10.2147/dmso.s628886},
  url = {https://doi.org/10.2147/dmso.s628886}
}

RIS

TY  - JOUR
TI  - SGLT-2 Inhibitors versus GLP-1 Receptor Agonists for Dementia and Depression in Type 2 Diabetes Mellitus: A Meta-Analysis.
AU  - Pan R
AU  - Wang B
AU  - Li Y
AU  - Li H
AU  - Liang X
AU  - Zhang Y
AU  - Liu X
AU  - Huang X
AU  - Wang R
AU  - Ji H
AU  - Zhao Y
PY  - 2026
JO  - Diabetes, metabolic syndrome and obesity : targets and therapy
DO  - 10.2147/dmso.s628886
UR  - https://doi.org/10.2147/dmso.s628886
ER  - 

APA

R, P., B, W., Y, L., H, L., X, L., Y, Z., X, L., X, H., R, W., H, J., & Y, Z. (2026). SGLT-2 Inhibitors versus GLP-1 Receptor Agonists for Dementia and Depression in Type 2 Diabetes Mellitus: A Meta-Analysis.. Diabetes, metabolic syndrome and obesity : targets and therapy. https://doi.org/10.2147/dmso.s628886

Source records